973 related articles for article (PubMed ID: 16150940)
1. Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001.
Morton LM; Wang SS; Devesa SS; Hartge P; Weisenburger DD; Linet MS
Blood; 2006 Jan; 107(1):265-76. PubMed ID: 16150940
[TBL] [Abstract][Full Text] [Related]
2. Racial differences in three major NHL subtypes: descriptive epidemiology.
Li Y; Wang Y; Wang Z; Yi D; Ma S
Cancer Epidemiol; 2015 Feb; 39(1):8-13. PubMed ID: 25560974
[TBL] [Abstract][Full Text] [Related]
3. Lymphoma survival patterns by WHO subtype in the United States, 1973-2003.
Han X; Kilfoy B; Zheng T; Holford TR; Zhu C; Zhu Y; Zhang Y
Cancer Causes Control; 2008 Oct; 19(8):841-58. PubMed ID: 18365759
[TBL] [Abstract][Full Text] [Related]
4. Lymphoid neoplasm incidence by WHO subtype in Australia 1982-2006.
van Leeuwen MT; Turner JJ; Joske DJ; Falster MO; Srasuebkul P; Meagher NS; Grulich AE; Giles GG; Vajdic CM
Int J Cancer; 2014 Nov; 135(9):2146-56. PubMed ID: 24639369
[TBL] [Abstract][Full Text] [Related]
5. Incidence of extranodal non-Hodgkin lymphomas among whites, blacks, and Asians/Pacific Islanders in the United States: anatomic site and histology differences.
Wu XC; Andrews P; Chen VW; Groves FD
Cancer Epidemiol; 2009 Nov; 33(5):337-46. PubMed ID: 19853554
[TBL] [Abstract][Full Text] [Related]
6. Incidence of lymphoid neoplasms by subtype among six Asian ethnic groups in the United States, 1996-2004.
Carreon JD; Morton LM; Devesa SS; Clarke CA; Gomez SL; Glaser SL; Sakoda LC; Linet MS; Wang SS
Cancer Causes Control; 2008 Dec; 19(10):1171-81. PubMed ID: 18543071
[TBL] [Abstract][Full Text] [Related]
7. Cancer incidence in France over the 1980-2012 period: Hematological malignancies.
Le Guyader-Peyrou S; Belot A; Maynadié M; Binder-Foucard F; Remontet L; Troussard X; Bossard N; Monnereau A;
Rev Epidemiol Sante Publique; 2016 Apr; 64(2):103-12. PubMed ID: 26973179
[TBL] [Abstract][Full Text] [Related]
8. Racial differences in the presentation and outcomes of chronic lymphocytic leukemia and variants in the United States.
Shenoy PJ; Malik N; Sinha R; Nooka A; Nastoupil LJ; Smith M; Flowers CR
Clin Lymphoma Myeloma Leuk; 2011 Dec; 11(6):498-506. PubMed ID: 21889433
[TBL] [Abstract][Full Text] [Related]
9. Second malignancy risks after non-Hodgkin's lymphoma and chronic lymphocytic leukemia: differences by lymphoma subtype.
Morton LM; Curtis RE; Linet MS; Bluhm EC; Tucker MA; Caporaso N; Ries LA; Fraumeni JF
J Clin Oncol; 2010 Nov; 28(33):4935-44. PubMed ID: 20940199
[TBL] [Abstract][Full Text] [Related]
10. Chronic lymphocytic leukaemia and small lymphocytic lymphoma: overview of the descriptive epidemiology.
Dores GM; Anderson WF; Curtis RE; Landgren O; Ostroumova E; Bluhm EC; Rabkin CS; Devesa SS; Linet MS
Br J Haematol; 2007 Dec; 139(5):809-19. PubMed ID: 17941952
[TBL] [Abstract][Full Text] [Related]
11. Relationship between ambient ultraviolet radiation and non-Hodgkin lymphoma subtypes: a U.S. population-based study of racial and ethnic groups.
Cahoon EK; Pfeiffer RM; Wheeler DC; Arhancet J; Lin SW; Alexander BH; Linet MS; Freedman DM
Int J Cancer; 2015 Mar; 136(5):E432-41. PubMed ID: 25258118
[TBL] [Abstract][Full Text] [Related]
12. Lymphoid malignancies in U.S. Asians: incidence rate differences by birthplace and acculturation.
Clarke CA; Glaser SL; Gomez SL; Wang SS; Keegan TH; Yang J; Chang ET
Cancer Epidemiol Biomarkers Prev; 2011 Jun; 20(6):1064-77. PubMed ID: 21493873
[TBL] [Abstract][Full Text] [Related]
13. Changes in cancer registry coding for lymphoma subtypes: reliability over time and relevance for surveillance and study.
Clarke CA; Undurraga DM; Harasty PJ; Glaser SL; Morton LM; Holly EA
Cancer Epidemiol Biomarkers Prev; 2006 Apr; 15(4):630-8. PubMed ID: 16614102
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular mortality among patients with non-Hodgkin lymphoma: Differences according to lymphoma subtype.
Abuamsha H; Kadri AN; Hernandez AV
Hematol Oncol; 2019 Aug; 37(3):261-269. PubMed ID: 30916804
[TBL] [Abstract][Full Text] [Related]
15. Cancer surveillance series: non-Hodgkin's lymphoma incidence by histologic subtype in the United States from 1978 through 1995.
Groves FD; Linet MS; Travis LB; Devesa SS
J Natl Cancer Inst; 2000 Aug; 92(15):1240-51. PubMed ID: 10922409
[TBL] [Abstract][Full Text] [Related]
16. Distribution of lymphoid neoplasms in the Republic of Korea: analysis of 5318 cases according to the World Health Organization classification.
Yoon SO; Suh C; Lee DH; Chi HS; Park CJ; Jang SS; Shin HR; Park BH; Huh J
Am J Hematol; 2010 Oct; 85(10):760-4. PubMed ID: 20806229
[TBL] [Abstract][Full Text] [Related]
17. Plasma Cell Myeloma - 20-Year Comparative Survival and Mortality of Three Plasma Cell Myeloma ICD-O-3 Oncologic Phenotypes by Age, Sex, Race, Stage, Cohort Entry Time-Period and Disease Duration: A Systematic Review of 111,041 Cases for Diagnosis Years 1973-2014: (SEER*Stat 8.3.4).
Milano AF
J Insur Med; 2018; 47(4):203-211. PubMed ID: 30668210
[TBL] [Abstract][Full Text] [Related]
18. Subtype distribution of lymphomas in South of Iran, analysis of 1085 cases based on World Health Organization classification.
Monabati A; Safaei A; Noori S; Mokhtari M; Vahedi A
Ann Hematol; 2016 Mar; 95(4):613-8. PubMed ID: 26754635
[TBL] [Abstract][Full Text] [Related]
19. Racial Patterns of Peripheral T-Cell Lymphoma Incidence and Survival in the United States.
Adams SV; Newcomb PA; Shustov AR
J Clin Oncol; 2016 Mar; 34(9):963-71. PubMed ID: 26962200
[TBL] [Abstract][Full Text] [Related]
20. Characterizing Lymphoma Incidence and Disparities for a Cancer Center Catchment Region.
Ayers AA; Lyu L; Dance K; Ward KC; Flowers CR; Koff JL; McCullough LE
Clin Lymphoma Myeloma Leuk; 2019 Nov; 19(11):699-708.e5. PubMed ID: 31494062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
